272 related articles for article (PubMed ID: 17652794)
1. Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study.
Albores-Saavedra J; Henson DE; Glazer E; Schwartz AM
Endocr Pathol; 2007; 18(1):1-7. PubMed ID: 17652794
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.
Aschebrook-Kilfoy B; Ward MH; Sabra MM; Devesa SS
Thyroid; 2011 Feb; 21(2):125-34. PubMed ID: 21186939
[TBL] [Abstract][Full Text] [Related]
3. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].
Hundahl SA; Fleming ID; Fremgen AM; Menck HR
Cancer; 1998 Dec; 83(12):2638-48. PubMed ID: 9874472
[TBL] [Abstract][Full Text] [Related]
4. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival.
Colonna M; Bossard N; Guizard AV; Remontet L; Grosclaude P;
Ann Endocrinol (Paris); 2010 Mar; 71(2):95-101. PubMed ID: 20036351
[TBL] [Abstract][Full Text] [Related]
5. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
Oyer SL; Fritsch VA; Lentsch EJ
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
[TBL] [Abstract][Full Text] [Related]
6. Follicular thyroid cancer incidence patterns in the United States, 1980-2009.
Aschebrook-Kilfoy B; Grogan RH; Ward MH; Kaplan E; Devesa SS
Thyroid; 2013 Aug; 23(8):1015-21. PubMed ID: 23360496
[TBL] [Abstract][Full Text] [Related]
7. Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.
Lin JD; Hsueh C; Chao TC
Thyroid; 2009 Oct; 19(10):1053-9. PubMed ID: 19772423
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
[TBL] [Abstract][Full Text] [Related]
9. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
10. Childhood thyroid cancer in England and Wales.
Harach HR; Williams ED
Br J Cancer; 1995 Sep; 72(3):777-83. PubMed ID: 7669594
[TBL] [Abstract][Full Text] [Related]
11. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
12. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.
Milano AF
J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997-2008.
Veiga LH; Neta G; Aschebrook-Kilfoy B; Ron E; Devesa SS
Thyroid; 2013 Jun; 23(6):748-57. PubMed ID: 23410185
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
[TBL] [Abstract][Full Text] [Related]
15. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
16. Follicular variant papillary thyroid carcinoma in a pediatric population.
Lerner J; Goldfarb M
Pediatr Blood Cancer; 2015 Nov; 62(11):1942-6. PubMed ID: 26131690
[TBL] [Abstract][Full Text] [Related]
17. Population-based outcomes for pediatric thyroid carcinoma.
Shapiro NL; Bhattacharyya N
Laryngoscope; 2005 Feb; 115(2):337-40. PubMed ID: 15689762
[TBL] [Abstract][Full Text] [Related]
18. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
19. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.
Du L; Wang Y; Sun X; Li H; Geng X; Ge M; Zhu Y
BMC Cancer; 2018 Mar; 18(1):291. PubMed ID: 29544469
[TBL] [Abstract][Full Text] [Related]
20. Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece.
Tzavara I; Vlassopoulou B; Alevizaki C; Koukoulis G; Tzanela M; Koumoussi P; Sotsiou F; Thalassinos N
Clin Endocrinol (Oxf); 1999 May; 50(5):643-54. PubMed ID: 10468931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
